Search results for " Cytiva"

Article Real-Time Characterization of Biotherapeutics and Comparability of Biosimilars
Real-Time Characterization of Biotherapeutics and Comparability of Biosimilars A major advantage of SPR-based analysis is its ability to estimate the association and dissociation rate constants, an …

Article Single-use Bioreactors Have Reached the Big Time
…ions from our customers,” asserts Morgan Norris, general manager of upstream and cell culture with Cytiva. Whereas the first disposable bioreactors were ‘plastic’ copies of their stainless-steel …

Article Process Chromatography Selection for Downstream Processing Applications
In this roundtable discussion, industry experts Tomas Björkman, senior scientist, R&D at Cytiva; Alejandro Becerra-Arteaga, PhD, purification team manager, MSAT at MilliporeSigma; and Peter Levison, P…

Article Implementation of Raw Material Control Strategies in the Manufacture of Single-Use Bioprocessing Containers
Cellbag culture chambers (containers) were manufactured at a Cytiva pilot manufacturing facility in Westborough, MA, US. Gamma irradiation of containers was performed by Steris Isomedix, Northborough,…

Article Trends in Single-use Bioreactors
Representatives from industry supplier companies address innovations, reliability, barriers to adoption, and the role of singIe-use bioreactors in bioprocessing. By: Randi Hernandez Whil…

Article Optimizing Resin Performance with Disposable Chromatography Solutions
Shawn Knol/GETTY IMAGES By: Randi Hernandez BioPharm International, spoke to Fredrik Lundström, product manager, Cytiva; Jonathan Royce, bioprocess senior product manager of antibody affinity …

Article Challenges and Trends in Biopharma Facility Design
BioPharm International spoke with Daniella Kranjac, head, evaluation and offering, Enterprise Solutions, at Cytiva; Mario Philips, president of Single-Use Technologies at Pall Life Sciences; Par Almhe…

Article Webinar about a new affinity chromatography technology for recombinant proteins
Introducing new Cytiva™ Protein Select™ resin for recombinant protein purification in research and process development On November 15, 2023, Cytiva announced the upcoming l…

Article Flexible Facilities for Viral Vector Manufacturing
It’s critical to have a facility design that is flexible enough to adapt to product pipeline diversity,” says Joe Makowiecki, Enterprise Solutions director of business development at Cytiva. Modul…

Article A Look at the Affinity Chromatography Landscape
…shes to prevent biocontamination, according to Eva Heldin, section manager for bioprocess R&D at Cytiva. To meet this need, in 2017 the company developed a new Protein A ligand that offers both great…

Previous PageNext Page